MARKET

KTOV

KTOV

Kitov Pharms
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.7300
+0.0155
+2.17%
Closed 16:00 11/20 EST
OPEN
0.7173
PREV CLOSE
0.7145
HIGH
0.7326
LOW
0.7010
VOLUME
39.30K
TURNOVER
--
52 WEEK HIGH
2.920
52 WEEK LOW
0.5600
MARKET CAP
584.33K
P/E (TTM)
-0.3346
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of KTOV and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

KTOV News

  • Kitov: Consensi Commercial Update Supports Value Buy
  • Seeking Alpha - Article.10/17 17:49
  • Kitov Pharma amends marketing agreement for Consensi; shares up 11% premarket
  • seekingalpha.10/11 18:06
  • Kitov Reports Coeptis Pharma Engaged Distribution Partner With Sales Network, Pharmacies Nationwide
  • Benzinga.10/11 12:55
  • Kitov Reports Amended Marketing, Distribution Deal With Coeptis, Will Receive $99.5M In Milestone, Reimbursement Payments Plus 20% Royalties
  • Benzinga.10/11 12:54

More

Industry

Biotechnology & Medical Research
+0.65%
Pharmaceuticals & Medical Research
-0.14%

Hot Stocks

Name
Price
%Change

About KTOV

Kitov Pharma Ltd, formerly Kitov Pharmaceuticals Holdings Ltd, is an Israel-based company that develops non-steroidal anti-inflammatory drugs that treat pain without raising blood pressure, thus avoiding the increased risk of heart attacks, strokes or death.
More

Webull offers Kitov Pharma Ltd (KTOV) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.